Grifols is a global company that since 1909 has enhanced the health and well-being of people around the world. Our four divisions - Bioscience, Diagnostic, Hospital, and Bio Supplies - develop, produce, and market innovative solutions and services in more than 100 countries.
Commitment to Society
Our mission is to improve the health and well-being of patients around the world. Since 1909, we have advanced science, inspired innovation, and supported the scientific community and its research efforts worldwide.
Commitment to Donors & Patients
Thanks to our donors' generosity we develop essential plasma medicines to treat chronic, rare and, at times, life-threatening conditions. We also provide diagnostic solutions, instruments, and services for blood banks, donation centers, hospitals, and pharmacies.
Find out more about Grifols' International Headquarters
- New Zealand
- Czech Republic
- San Marino
- Slovak Republic
- Spain (Headquarters)
- United Kingdom
- Costa Rica
- Dominican Republic
- El Salvador
- Trinidad and Tobago
- Dubai (United Arab Emirates)
- Hong Kong SAR
- Saudi Arabia
- Singapore (Asia Pacific)
- South Korea
- Sri Lanka
- Taiwan, China
- Cape Verde
- São Tomé and Príncipe
We trace our roots back to 1909 when Dr. Josep Antoni Grifols i Roig founded the laboratory Instituto Central de Análisis Clínicos, Bacteriológicos y Químicos in Barcelona.
The Grifols Hemophilia Awareness Global Awards (GHAGA)
A periodic award focused on encouraging healthcare providers, hemophilia treatment centers, as well as hemophilia societies to submit proposals that would contribute to improving the care of hemophilia patients and enhancing their quality of life.
April 7, 2021
Grifols advances in the execution of its expansion plan with the acquisition of 7 plasma centers in the U.S.
April 2, 2021
Grifols announces topline data from NIAID Phase 3 ITAC trial (INSIGHT-013) evaluating hyperimmune globulins as a treatment for hospitalized patients with COVID-19
Our business is organized into four divisions: Bioscience, Diagnostic, Hospital, and Bio Supplies.
We are committed to a long-term vision that creates a sustainable, positive impact on the communities in which we operate.
Since Grifols was founded, our ongoing innovation has helped shape industry standards in the plasma industry.
This information is aimed exclusively at authorized healthcare professionals to prescribe or supply medicinal products and its correct interpretation requires specialized training.
Are you a healthcare professional?